Market Overview

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Albany Molecular Research, Inc.

Share:

Robbins
Geller Rudman & Dowd LLP
("Robbins Geller") today announced that
a class action has been commenced on behalf of holders of Albany
Molecular Research, Inc. ("AMRI") (NASDAQ:AMRI) stockholders as of July
10, 2017. This action was filed in the Northern District of New York and
is captioned Rodak v. D'Ambra, et al., No. 1:17-cv-01179.

If you wish to serve as lead plaintiff, you must move the Court no later
than 60 days from today. If you wish to discuss this action or have any
questions concerning this notice or your rights or interests, please
contact plaintiff's counsel, Darren
Robbins
of Robbins Geller at 800/449-4900 or 619/231-1058, or via
e-mail at djr@rgrdlaw.com. Any
member of the putative class may move the Court to serve as lead
plaintiff through counsel of their choice, or may choose to do nothing
and remain an absent class member.

The complaint charges AMRI, certain of its senior officers and directors
and UIC Parent Corporation and UIC Merger Sub, Inc. (collectively,
"UIC"), which were formed and are controlled by affiliates of The
Carlyle Group, L.P. and Carlyle Investment Management L.L.C.
(collectively, "Carlyle") and affiliates of GTCR LLC (collectively,
"GTCR"), with violations of the Securities Exchange Act of 1934 ("1934
Act"). AMRI was a global contract research and manufacturing
organization that had been working with the life sciences sector and
pharmaceutical industry to improve patient outcomes and the quality of
life for more than two decades.

On June 5, 2017, AMRI and UIC entered into an Agreement and Plan of
Merger (the "Merger Agreement"). Under the Merger Agreement, AMRI's
Board of Directors (the "Board") agreed to the acquisition of AMRI by
Carlyle and GTCR in exchange for $21.75 per share in cash (the "Merger").

The complaint alleges that in order to make the Merger price appear
attractive to AMRI's outside stockholders, on July 14, 2017, the
defendants issued a proxy statement recommending approval of the Merger
(the "Proxy Statement") that contained materially false and misleading
information and omitted other material information that was necessary to
make the information that was disclosed not misleading, in violation of
§14(a) of the 1934 Act. Most notably, in contrast to the Company's
actual expected growth, the financial projections that were disclosed in
the Proxy Statement, and were relied upon by the Board's financial
advisor in opining that the Merger price was fair to stockholders, were
falsely pessimistic, as demonstrated by defendants' own prior
statements. These downwardly manipulated financial projections were
central to the Proxy Statement and to the defendants' advocacy of the
Merger.

According to the complaint, as a result of these and other materially
false and misleading statements and/or omissions in the Proxy Statement,
defendants were able to obtain stockholder approval of the sale of the
Company to Carlyle and GTCR and deprive AMRI stockholders of the full
value of their interest in AMRI. On August 18, 2017, a majority of AMRI
stockholders voted in favor of the Merger Agreement. On August 31, 2017,
the Merger closed. The preparation and dissemination of the false and
misleading Proxy Statement thus induced stockholder action that resulted
in substantial harm to plaintiff and AMRI's other stockholders.

Plaintiff seeks to recover damages on behalf of all stockholders of AMRI
as of July 10, 2017 (the "Class"). The plaintiff is represented by
Robbins Geller, which has extensive experience in prosecuting investor
class actions including actions involving financial fraud.

Robbins Geller is widely recognized as a leading law firm advising and
representing U.S. and international investors in securities litigation
and portfolio monitoring. With 200 lawyers in 10 offices, Robbins Geller
has obtained many of the largest securities class action recoveries in
history. For the third consecutive year, the Firm ranked first in both
the total amount recovered for investors and the number of shareholder
class action recoveries in ISS's SCAS Top 50 Report. Robbins Geller
attorneys have shaped the law in the areas of securities litigation and
shareholder rights and have recovered tens of billions of dollars on
behalf of the Firm's clients. Robbins Geller not only secures recoveries
for defrauded investors, it also implements significant corporate
governance reforms, helping to improve the financial markets for
investors worldwide. Please visit http://www.rgrdlaw.com
for more information.

https://www.linkedin.com/company/rgrdlaw
https://twitter.com/rgrdlaw
https://www.facebook.com/rgrdlaw
https://plus.google.com/+Rgrdlaw/posts

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com